Letarium Letrozole Tablets 2.5 mg is a prescription oral oncology medicine identified as containing Letrozole 2.5 mg per tablet.

Letrozole is a nonsteroidal aromatase inhibitor used as endocrine therapy for selected hormone receptor-positive breast cancers.

It works by inhibiting the aromatase enzyme, which is responsible for producing estrogen from androgen precursors.

By reducing estrogen production, letrozole can slow the growth of estrogen-dependent breast cancer cells.

Letrozole is used in selected early, advanced and metastatic breast cancer treatment settings, particularly in postmenopausal patients.

It may also be prescribed with other anticancer medicines, including certain CDK4/6 inhibitors, when clinically indicated.

The exact manufacturer, pack size, tablet composition, storage conditions and approved indications of Letarium must be verified from its approved Indian product documentation.

Marketed by Essentials Emporium Enterprises, Letarium is listed within the oncology pharmaceutical category for hospitals, cancer treatment centres and authorized pharmaceutical buyers.

Key Product Features